Corporations
make a difference

Read more

Treatment

The ARSACS Foundation is now
working with pharmaceutical companies
to develop a treatment for ARSACS

Read more

Several research projects
are currently funded
by the Foundation
in Canada and abroad

Read more

The Ataxia gene can be
passed through many generations
without manifesting any symptoms

Read more

We need your support
to pursue research that heals

How can you help?

Donate
`

Latest News

Jan

20

2015

Audrey and Danny's initiative raised $1050 for ARSACS research

Audrey Bouchard and Danny Laberge took advantage of the holiday season to sell Christmas cakes. Their initiative raised $1050 for ARSACS research. Thank you to both of you and to your family members and friends in Saguenay and Pont-Rouge for your support to the cause.

Jan

16

2015

Chronic studies in ARSACS mice to be conducted

Activities are currently underway to conduct chronic studies on the administration of a drug in ARSACS mice. A preliminary study was done in 2013 and had positive results. This time, the studies will be done over a longer period of time. More details to come.

Jan

14

2015

ASRSACS panel discussions at the CIHR Cafés scientifiques

A video of the panel discussions on ARSACS at the CIHR Cafés scientifiques held in November 2014.Panel discussions.

Jan

13

2015

2015 "European Research Projects on Rare Diseases" Joint Transnational Call

CIHR Institute of Genetics to participate in the 2015 "European Research Projects on Rare Diseases" Joint Transnational Call.

Read More

Jan

08

2015

International Ataxia Research Conference in March 2015

The International Ataxia Research Conference (ARC) will be held from March 25th to 28th,2015 at the Beaumont Estate, Windsor, UK. Prior to the conference,an ARSACS meeting will be held at the same location on March 23rd to discuss the outcome measures in ARSACS.

Dec

26

2014

The "Dîner des Producteurs 2014"- a great success!

The "Dîner des Producteurs" was very successful again this year. This well attended annual fund raising event contributed over $700,000 to the ARSCAS research. The Ataxia Charlevoix -Saguenay Foundation would like to thank first and foremost the attendees and donors for their participation and generosity and a special thank you to the chefs, organisors, sponsors, and volunteers who make the event happen for the enjoyment of all.

Read More

Dec

26

2014

Third international symposium on ARSACS

The 3rd symposium on ARSACS was well attended on November 12th and 13th,2014 in Montreal.Several experts in the field shared their knowledge and experience on the subject. Symposium Program.

Read More

Nov

20

2014

The Foundation is funding six new research projects

The Foundation of Ataxia Charlevoix-Saguenay is funding six new ARSACS research projects for 2014-2015.

Read More


Who We Are


What We Do

Funding
Funding
process
Team
Research
Research
process
Discovery
Trials
Trials

The Ataxia Charlevoix-Saguenay Foundation is a charitable organisation supported entirely by private donations. Different events are organised during the year by families, friends and community groups to raise funds to support research on ARSACS.


Since its creation, the Foundation has been successful in assembling a great team at all levels of the organisation (board, advisors, researchers, contributors and partners). The researchers are well respected in their field and have an international reputation for excellence.


The main research objective of the Ataxia Charlevoix-Saguenay Foundation is to develop a treatment for ARSACS. Several research projects on ARSACS are currently funded by the Foundation in Canada and abroad. Over 98% of the funds raised are allocated to research.


The main research objective of the Ataxia Charlevoix-Saguenay Foundation is to develop a treatment for ARSACS.


The first therapeutic tests on transgenic ARSACS mice conducted in the Spring 2013 were very positive. For a short study, the tests demonstrated some beneficial effect on the physical performance of the mice. Discussions are underway to determine the next step.